Artiva Biotherapeutics (ARTV) Return on Assets (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Return on Assets for 2 consecutive years, with 0.6% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 31.0% to 0.6% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.6%, a 31.0% decrease, with the full-year FY2025 number at 0.49%, down 8.0% from a year prior.
  • Return on Assets was 0.6% for Q4 2025 at Artiva Biotherapeutics, down from 0.5% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.28% in Q4 2024 to a low of 0.6% in Q4 2025.